Principal Financial Group
DSGN icon

Principal Financial Group’s Design Therapeutics DSGN Stock Holding History

Principal Financial Group’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,497
Closed -$50.4K – 2396
2024
Q1 		$50.4K Sell
12,497
-2,719
-18% -$7.26K ﹤0.01% 2343
2023
Q4 		$40.3K Sell
15,216
-701,602
-98% -$1.61M ﹤0.01% 2346
2023
Q3 		$1.69M Sell
716,818
-11,403
-2% -$53.2K ﹤0.01% 1785
2023
Q2 		$4.59M Buy
728,221
+8,284
+1% +$50.7K ﹤0.01% 1556
2023
Q1 		$4.15M Sell
719,937
-62,772
-8% -$470K ﹤0.01% 1599
2022
Q4 		$8.03M Sell
782,709
-37,277
-5% -$505K 0.01% 1356
2022
Q3 		$13.7M Buy
819,986
+66,293
+9% +$1.32M 0.01% 1007
2022
Q2 		$10.6M Buy
753,693
+209,781
+39% +$2.83M 0.01% 1227
2022
Q1 		$8.78M Buy
543,912
+21,458
+4% +$329K 0.01% 1445
2021
Q4 		$11.2M Buy
522,454
+301,944
+137% +$5.18M 0.01% 1331
2021
Q3 		$3.24M Buy
220,510
+9,008
+4% +$150K ﹤0.01% 1791
2021
Q2 		$4.21M Buy
211,502
+104,094
+97% +$2.63M ﹤0.01% 1760
2021
Q1 		$3.21M Buy
+107,408
New +$3.62M ﹤0.01% 1771

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group's DSGN Position: Q2 2024 in Review

Principal Financial Group sold out of Design Therapeutics (DSGN) in Q2 2024, closing a stake of 12,497 shares — an estimated $50.4K sold.

Principal Financial Group first reported a position in DSGN in Q1 2021 and held it in 13 quarters. The position peaked at $13.7M in Q3 2022. 95 funds tracked by Wall St. Rank hold DSGN as of Q2 2024.

  • Principal Financial Group reported no remaining Design Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Principal Financial Group sold 12,497 Design Therapeutics shares in Q2 2024, an estimated $50.4K.
  • Principal Financial Group first reported a position in Design Therapeutics in Q1 2021 and held it in 13 quarters.
  • Principal Financial Group's Design Therapeutics position peaked at $13.7M in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2024.

Based on Principal Financial Group's 13F filing for Q2 2024, filed 29 Jul 2024.